The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-ethylphenyl)-2-(4-((4-(4-oxo-3-(phenylamino)-1,2,3,4-tetrahydroquinazolin-2-yl)phenoxy)methyl)-1H-1,2,3-triazol-1-yl)acetamide ID: ALA5287039
Max Phase: Preclinical
Molecular Formula: C33H31N7O3
Molecular Weight: 573.66
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCc1ccc(NC(=O)Cn2cc(COc3ccc(C4Nc5ccccc5C(=O)N4Nc4ccccc4)cc3)nn2)cc1
Standard InChI: InChI=1S/C33H31N7O3/c1-2-23-12-16-25(17-13-23)34-31(41)21-39-20-27(36-38-39)22-43-28-18-14-24(15-19-28)32-35-30-11-7-6-10-29(30)33(42)40(32)37-26-8-4-3-5-9-26/h3-20,32,35,37H,2,21-22H2,1H3,(H,34,41)
Standard InChI Key: TVEIVTCWXIHVCN-UHFFFAOYSA-N
Molfile:
RDKit 2D
43 48 0 0 0 0 0 0 0 0999 V2000
-6.4641 1.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4641 0.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7507 0.4811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0436 0.8912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0436 1.7129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7525 2.1230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3320 2.1237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6204 1.7128 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6204 0.8912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3320 0.4803 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9088 0.4803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9088 -0.3448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1952 -0.7514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4879 -0.3412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7763 -0.7520 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0647 -0.3412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6469 -0.7520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7327 -1.5688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5361 -1.7396 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9467 -1.0283 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7684 -1.0283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1792 -1.7399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7684 -2.4515 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0010 -1.7399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4118 -2.4515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2335 -2.4515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6425 -3.1616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2315 -3.8751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4139 -3.8751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9992 -3.1662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3971 -0.4179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4879 0.4807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1970 0.8910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9088 2.1237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9088 2.9454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6196 3.3564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6196 4.1757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9077 4.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1941 4.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1941 3.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3320 2.9454 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6424 -4.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4641 -4.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 1 2 0
5 7 1 0
8 7 1 0
9 8 1 0
10 9 1 0
4 10 1 0
11 9 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
18 17 1 0
19 18 2 0
20 19 1 0
20 21 1 0
21 22 1 0
22 23 2 0
22 24 1 0
24 25 1 0
26 25 2 0
27 26 1 0
28 27 2 0
29 28 1 0
30 29 2 0
25 30 1 0
31 20 1 0
31 17 2 0
32 14 2 0
32 33 1 0
33 11 2 0
8 34 1 0
34 35 1 0
36 35 2 0
37 36 1 0
38 37 2 0
39 38 1 0
40 39 2 0
35 40 1 0
7 41 2 0
28 42 1 0
42 43 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 573.66Molecular Weight (Monoisotopic): 573.2488AlogP: 5.65#Rotatable Bonds: 10Polar Surface Area: 113.41Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.70CX Basic pKa: ┄CX LogP: 6.72CX LogD: 6.72Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.20Np Likeness Score: -1.45
References 1. Moghadam Farid S, Iraji A, Mojtabavi S, Ghasemi M, Faramarzi MA, Mahdavi M, Barazandeh Tehrani M, Akbarzadeh T, Saeedi M.. (2023) Quinazolinone-1,2,3-triazole-acetamide conjugates as potent α-glucosidase inhibitors: synthesis, enzyme inhibition, kinetic analysis, and molecular docking study., 14 (3): [PMID:36970140 ] [10.1039/d2md00297c ]